Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
VVUS [NASD]
VIVUS Inc.
Index- P/E- EPS (ttm)-1.73 Insider Own0.10% Shs Outstand103.30M Perf Week8.83%
Market Cap547.49M Forward P/E- EPS next Y-1.24 Insider Trans0.06% Shs Float102.45M Perf Month-9.25%
Income-174.90M PEG- EPS next Q-0.38 Inst Own85.80% Short Float32.62% Perf Quarter-40.05%
Sales81.10M P/S6.75 EPS this Y-21.80% Inst Trans-0.19% Short Ratio9.68 Perf Half Y-45.86%
Book/sh1.50 P/B3.53 EPS next Y25.30% ROA-46.80% Target Price8.11 Perf Year-56.34%
Cash/sh3.32 P/C1.59 EPS next 5Y8.40% ROE-104.50% 52W Range4.71 - 15.62 Perf YTD-41.63%
Dividend- P/FCF- EPS past 5Y-65.30% ROI-42.20% 52W High-66.45% Beta1.51
Dividend %- Quick Ratio7.20 Sales past 5Y-0.60% Gross Margin81.40% 52W Low11.25% ATR0.27
Employees98 Current Ratio8.20 Sales Q/Q2135.30% Oper. Margin- RSI (14)42.70 Volatility5.25% 5.36%
OptionableYes Debt/Eq1.39 EPS Q/Q69.60% Profit Margin- Rel Volume0.42 Prev Close5.30
ShortableYes LT Debt/Eq1.39 EarningsMay 05 Payout- Avg Volume3.45M Price5.24
Recom3.30 SMA20-3.11% SMA50-11.58% SMA200-44.27% Volume713,701 Change-1.13%
25-Feb-14Reiterated WallachBeth Hold $11 → $8
15-Nov-13Initiated WallachBeth Hold $11
03-Oct-13Upgrade Cowen Hold → Outperform $19
19-Jul-13Downgrade Needham Buy → Hold
18-Jan-13Reiterated MLV & Co Buy $40 → $21
24-Sep-12Reiterated Needham Buy $38 → $32
19-Jul-12Reiterated MLV & Co Buy $34 → $40
18-Jul-12Reiterated Rodman & Renshaw Mkt Outperform $39 → $52
18-Jul-12Downgrade Brean Murray Buy → Hold
30-Apr-12Reiterated MLV & Co Buy $30 → $34
23-Feb-12Upgrade Rodman & Renshaw Mkt Perform → Mkt Outperform $39
23-Feb-12Upgrade Brean Murray Sell → Hold $2
23-Feb-12Reiterated MLV & Co Buy $22 → $30
23-Feb-12Reiterated JMP Securities Mkt Outperform $16 → $45
17-Jan-12Reiterated MLV & Co Buy $16 → $22
05-Jan-12Initiated Rodman & Renshaw Mkt Perform
29-Oct-10Reiterated JMP Securities Mkt Outperform $12 → $16
03-Aug-10Downgrade Brean Murray Hold → Sell $2
16-Jul-10Reiterated Wedbush Outperform $20 → $10
16-Jul-10Reiterated JMP Securities Mkt Outperform $18 → $12
21-Apr-14 11:13AM  Arena Pharmaceuticals' Belviq Sales Dip - Why? at Seeking Alpha
19-Apr-14 06:31PM  1 of These 3 Cratering Biotechs is a Buy at Motley Fool
14-Apr-14 05:58PM  Biotech Tweet of the Week: Love Being Private at Motley Fool
09:22AM  What Arena's Belviq Television Ad Campaign Means For The Stock at Seeking Alpha
11-Apr-14 01:54PM  Arena - Belviq Sales Up Modestly Heading Into Television Ads at Seeking Alpha
07:00AM  Avanafil Clinical Data to Be Presented at European Association of Urology Marketwired
08-Apr-14 05:01PM  VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
05:00PM  Three VIVUS Directors Not Standing for Re-Election Marketwired
07:00AM  VIVUS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
03-Apr-14 03:00PM  [video] 3 to Watch: ILMN, NFLX, VVUS at CNBC -6.15%
02:32PM  US STOCKS-Wall St slips as biotech, momentum stocks lead decline Reuters
02:19PM  Why Vivus (VVUS) Stock Is Plunging Today at TheStreet
12:40PM  VIVUS retreats after analyst cuts rating to sell equivalent at theflyonthewall.com
12:26PM  Midday movers: Google, Barnes & Noble, Netflix & more at CNBC
09:53AM  Wall St. Dips Ahead of March Jobs Report at New York Times
09:53AM  Markets Move Lower on Wall Street at New York Times
09:53AM  Market Declines as Reluctant Investors Await Release of March Employment Data at New York Times
09:14AM  On The Fly: Pre-market Movers at theflyonthewall.com
09:03AM  Morning Movers in Biotech: Medicines Co., Omeros Corporation, Opko Health, Inc. and VIVUS, Inc. at Motley Fool
07:39AM  Stock futures little changed ahead of initial claims data Reuters
07:00AM  VIVUS to Present at Upcoming Investor Conference Marketwired
01-Apr-14 05:31PM  Biotech Auxilium Boosts Position In Men's Health Care at Investor's Business Daily
02:19PM  Can Stendra Cure Vivus at Seeking Alpha
28-Mar-14 12:25PM  Arena - Scripts, Ads, Sales Reps at Seeking Alpha
27-Mar-14 03:45PM  New ED drug takes over March Madness at CNBC
12:40PM  Largest option trades in equities optionMONSTER
26-Mar-14 12:55PM  Vivus: Shares Are Oversold, Pressure Is On To Secure A Commercial Partner And Drive Market Penetration at Seeking Alpha
25-Mar-14 11:50AM  Weekly Three-Year Low Highlight: VVUS, RALY, WILN, COVS Gurufocus
09:25AM  Todays Top Biotech Stories: Halozyme, Exelixis, and VIVUS at Motley Fool
07:00AM  Newly Published Review Article Summarizes Cardiovascular Benefit-Risk Profile of Qsymia Marketwired
21-Mar-14 02:31PM  Better Chance of Making a Comeback: Amarin plc or VIVUS, Inc.? at Motley Fool
19-Mar-14 07:00AM  Shari Belafonte Partners With VIVUS to Encourage Adults to Speak With Their Doctors About Losing Weight and Treatment Options Now Available Marketwired
17-Mar-14 08:27AM  Arena Down With Overall Market - Sales Data No Help at Seeking Alpha
13-Mar-14 10:13AM  Could Orexigen Therapeutics Be Another Arena or VIVUS? at Motley Fool
08:30AM  Narrower Loss at Orexigen in Q4 Zacks
06-Mar-14 01:04PM  VIVUS INC Financials EDGAR Online Financials
07:43AM  The Zacks Analyst Blog Highlights: InterMune, Alexion, Regeneron, VIVUS and Arena Zacks
05-Mar-14 06:00AM  2 Biotech Stocks Under $10 to Trade at TheStreet
06:00AM  2 Biotech Stocks Under $10 to Trade
04-Mar-14 02:05PM  Have Anti-Obesity Drug Prospects Finally Gone Belly-Up? at Motley Fool
03-Mar-14 10:37AM  It's Always Darkest Before The Dawn: Why Vivus Could Double In Three Months And Triple In Twelve at Seeking Alpha
10:37AM  It's Always Darkest Before The Dawn: Why Vivus Could Double In Three Months And Triple In Twelve
02-Mar-14 08:11PM  3 Important Investing Lessons From the Oscars at Motley Fool
28-Feb-14 07:05PM  Activist Investors Agitating Biotechs Bring Multi-Bagger Returns at Motley Fool
05:28PM  Arena Prescription Sales Up: Stops Stock Slide at Seeking Alpha
05:28PM  Arena Prescription Sales Up: Stops Stock Slide
04:07PM  VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
11:20AM  Arena Posts Wider Loss, Misses Ests Zacks
10:42AM  Auxilium Q4 Beats Estimates, But Guidance Cautious at Investor's Business Daily
10:42AM  Auxilium Q4 Beats Estimates, But Guidance Cautious
06:02AM  VIVUS INC Files SEC form 10-K, Annual Report EDGAR Online
27-Feb-14 07:42PM  Arena Falls On Quarterly Results at Seeking Alpha
01:49AM  Arena Earnings On Tap at Seeking Alpha
26-Feb-14 12:22AM  Orexigen Sees Positives In European Application For Contrave at Seeking Alpha
25-Feb-14 08:32PM  Why SINA, VIVUS, and Tenet Healthcare Tumbled Today at Motley Fool -13.19%
05:03PM  Another Big Failure for VIVUS, Inc. at Motley Fool
01:28PM  VIVUS Chances of a Stock Double Shrinking at 24/7 Wall St.
12:59PM  Why VIVUS Inc. Shares Slimmed Down at Motley Fool
10:47AM  Why Vivus (VVUS) Is Down Today at TheStreet
09:33AM  Why VIVUS Inc. Is Falling Today at Motley Fool
09:30AM  Narrower-than-Expected Loss at VIVUS Zacks
08:32AM  Vivus Beats The Street - Sort Of at Seeking Alpha
24-Feb-14 06:59PM  VIVUS' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
05:25PM  VIVUS' Q4 Loss Shrinks 70% as Licensing Revenue Soars at Motley Fool
04:49PM  Cheaper Obesity Drugs Available (for Half of Some Americans) at Motley Fool
04:30PM  Vivus Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
04:25PM  Vivus, Inc. Discusses Q4 2013 Results (Webcast) at Seeking Alpha
04:19PM  Vivus Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
04:06PM  VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:00PM  VIVUS Reports Fourth Quarter and Year-End 2013 Financial Results GlobeNewswire
07:07AM  Q4 2013 Vivus Inc. Earnings Release - After Market Close CCBN
22-Feb-14 01:45PM  VIVUS, Inc. Earnings: What to Expect Monday at Motley Fool
21-Feb-14 09:59AM  Biotech Showdown: Arena Pharmaceuticals vs. VIVUS Inc. at Motley Fool
19-Feb-14 07:00AM  VIVUS Announces Date of Fourth Quarter and Year End 2013 Financial Results and Conference Call GlobeNewswire -5.56%
18-Feb-14 06:31PM  3 Catalysts Biotech Investors Must Watch in 2014 at Motley Fool +5.57%
14-Feb-14 06:31PM  Why Arena Pharmaceuticals, Inc. Investors Should Remain Wary at Motley Fool
10:58AM  Arena Pharmaceuticals: Is The Stock Attractively Priced? at Seeking Alpha
12-Feb-14 02:36PM  Can These Obesity Drug Stocks Bounce Back in 2014? at Motley Fool
10-Feb-14 11:48AM  Arena, Eisai announce Belviq deal with CVS AP
09:27AM  Arena Reaches Critical Point On Insurance Coverage at Seeking Alpha
31-Jan-14 02:09PM  Arena's Belviq Sees Traction Slip Ahead Of Advertising at Seeking Alpha
02:09PM  Arena's Belviq Sees Traction Slip Ahead Of Advertising
30-Jan-14 04:31PM  VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:31PM  VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers
24-Jan-14 04:31PM  VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:31PM  VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers
03:54PM  Arena Investors Await Strong Sales Data at Seeking Alpha
03:54PM  Arena Investors Await Strong Sales Data
21-Jan-14 07:05AM  VIVUS and Auxilium Announce FDA Acceptance of Supplemental Filing Seeking an Update of Prescribing Information for STENDRA (avanafil) PR Newswire
07:05AM  VIVUS and Auxilium Announce FDA Acceptance of Supplemental Filing Seeking an Update of Prescribing Information for STENDRA (avanafil)
07:00AM  VIVUS and Auxilium Announce FDA Acceptance of Supplemental Filing Seeking an Update of Prescribing Information for STENDRA (Avanafil) GlobeNewswire
07:00AM  VIVUS and Auxilium Announce FDA Acceptance of Supplemental Filing Seeking an Update of Prescribing Information for STENDRA (Avanafil)
18-Jan-14 02:07PM  Will Orexigen Win the Obesity Drug War? at Motley Fool
02:07PM  Will Orexigen Win the Obesity Drug War?
17-Jan-14 04:31PM  VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:31PM  VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers
01:52PM  Arena's Belviq Scripts Showing Traction - Vivus As Well at Seeking Alpha
01:52PM  Arena's Belviq Scripts Showing Traction - Vivus As Well
12:20PM  JPMorgan Healthcare Conference Highlights: Arena Pharmaceuticals, Inc. at Motley Fool
15-Jan-14 06:32PM  VIVUS, Inc. and Aetna Inc's New Weight Loss Plan at Motley Fool
VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. The company offers Qsymia, a drug for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index of 30 or greater, or 27 or greater in the presence of at least one weight-related comorbidity, such as hypertension, type 2 diabetes mellitus, or high cholesterol; and STENDRA, an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction. It is also developing Qsymia, which has completed Phase II clinical studies for the treatment of obstructive sleep apnea and diabetes. The company has an agreement with Mitsubishi Tanabe Pharma Corporation for the development and commercialization of avanafil, a PDE5 inhibitor compound for the oral and local treatment of male and female sexual dysfunction. VIVUS, Inc. was founded in 1991 and is headquartered in Mountain View, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fischer Seth H.Z.Chief Executive OfficerMar 11Buy6.073,08018,6953,080Mar 12 06:37 PM
DENNER ALEXANDER JDirectorNov 11Buy8.78149,7761,315,0332,573,943Nov 12 05:08 PM
DENNER ALEXANDER JDirectorNov 08Buy8.52417,0683,553,4192,424,167Nov 12 05:08 PM
MORRIS TIMOTHY EVP, Finance and CFOSep 05Option Exercise4.2310,65445,06610,654Sep 09 07:29 PM
MORRIS TIMOTHY EVP, Finance and CFOSep 05Sale11.9510,654127,2830Sep 09 07:29 PM
ASTRUE MICHAEL JDirectorSep 04Buy11.9610,000119,59710,000Sep 06 04:09 PM
BIRO JON C10% OwnerJun 27Buy12.852,00025,6994,000Jul 01 06:21 PM
MARIO ERNESTDirectorMay 29Buy14.6815,000220,20681,125May 30 01:54 PM